MediMix
@medi_mix
MediMix, your communication partner with a focus on quality information in easy consumable formats, tailor-made for medical specialists.
ID: 1642561920950575105
https://oncology.medimix.be/ 02-04-2023 16:17:55
995 Tweet
214 Takipçi
258 Takip Edilen
🧠 Head & Neck Highlight from #ASCO2025! Dr Willem Lybaert on: 🔹 Cemiplimab vs pembrolizumab in cutaneous SCC 🔹 Immunotherapy/ADC breakthroughs in NPC 🔹 HER2, AR, and triplet therapy in rare H&N tumours 🎥 Watch now bit.ly/4mLvOXR #MediMix #HeadNeckCancer #Oncology